Thyrocare Technologies Limited has informed the Exchange that the Board of Directors at its meeting held on October 14, 2025, has considered, approved, and recommended to the shareholders the issuance of bonus shares in the ratio of 2:1, i.e., 2 new equity shares for every 1 existing equity share, subject to the approval of the shareholders.